Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibody Persistence in Healthy South African Children After Primary Series and Booster Vaccination With an Investigational (DTaP-IPV-Hep B-PRP-T) or Control Vaccines

NCT01105559 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01105559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01105559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibody Persistence in Healthy South African Children After Primary Series and Booster Vaccination With an Investigational (DTaP-IPV-Hep B-PRP-T) or Control Vaccines
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
December 31, 2011
Enrollment
455 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, hepatitis b, poliomyelitis, tetanus, whooping cough